Journal of Clinical Endocrinology & Metabolism, Vol 57, 645-648, Copyright © 1983 by Endocrine Society

ARTICLES

Sex hormone-binding globulin changes with androgen replacement

SR Plymate, JM Leonard, CA Paulsen, BL Fariss and AE Karpas

Since sex hormone-binding globulin (SHBG) levels are often elevated in sera of patients with testicular insufficiency, it is important to determine whether SHBG declines into the normal range and the extent of change in free testosterone (free T) after androgen administration. Five normal men and five patients with Klinefelter's syndrome were studied before and after the administration of testosterone enanthate (200 mg, im every 2 weeks). An additional five normal men and five patients with hypogonadotropic hypogonadism (HH) were treated with hCG (2000 U, three times a week). Three months after the administration of T or hCG, serum total and free T increased in both normal men and patients. Free T increased significantly in the Klinefelter's and HH patients from 94 +/- 20 and 14 +/- 5 pg/ml, respectively, to 271 +/- 50 and 276 +/- 41 pg/ml (P less than 0.01; P less than 0.001). The increase in the normal men treated with T or hCG was also significant (from 211 +/- 52 and 220 +/- 37 pg/ml to 390 +/- 83 and 330 +/- 90 pg/ml). SHBG fell in both the T-treated normal men (from 6.5 +/- 1.2 ng dihydrotestosterone bound/ml to 4.3 +/- 0.4; P less than 0.02) and the T-treated Klinefelter's patients (from 16.4 +/- 2 to 4.3 +/- 0.5; P less than 0.01). However, it was unchanged in the hCG-treated HH patients and rose in the hCG-treated normal men (from 6.6 +/- 0.7 to 8.6 +/- 1.0; P less than 0.05). This study demonstrates that treatment of hypogonadal men with T and hCG in the doses used increased free T levels above the basal levels for normal men. However, the effects of the increase in free T, as determined by a change in SHBG, were different depending upon the type of treatment.

This article has been cited by other articles:

				A. J. Swerdlow, C. D. Higgins, M. J. Schoemaker, A. F. Wright, P. A. Jacobs, and on behalf of the United Kingdom Clinical Cytogenet Mortality in Patients with Klinefelter Syndrome in Britain: A Cohort Study J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6516 - 6522. [Abstract] [Full Text] [PDF]

				A. J. Swerdlow, M. J. Schoemaker, C. D. Higgins, A. F. Wright, P. A. Jacobs, and on behalf of the UK Clinical Cytogenetics Group Cancer Incidence and Mortality in Men with Klinefelter Syndrome: A Cohort Study J Natl Cancer Inst, August 17, 2005; 97(16): 1204 - 1210. [Abstract] [Full Text] [PDF]

				S G Beckham and C P Earnest Four weeks of androstenedione supplementation diminishes the treatment response in middle aged men Br. J. Sports Med., June 1, 2003; 37(3): 212 - 218. [Abstract] [Full Text] [PDF]

				N. Pascal, E. K. S. Amouzou, A. Sanni, F. Namour, I. Abdelmouttaleb, M. Vidailhet, and J.-L. Gueant Serum concentrations of sex hormone binding globulin are elevated in kwashiorkor and anorexia nervosa but not in marasmus Am. J. Clinical Nutrition, July 1, 2002; 76(1): 239 - 244. [Abstract] [Full Text] [PDF]

				A. Mifsud, A. T. Choon, D. Fang, and E.L. Yong Prostate-specific antigen, testosterone, sex-hormone binding globulin and androgen receptor CAG repeat polymorphisms in subfertile and normal men Mol. Hum. Reprod., November 1, 2001; 7(11): 1007 - 1013. [Abstract] [Full Text] [PDF]

				R. Pasquali, A. Gambineri, D. Biscotti, V. Vicennati, L. Gagliardi, D. Colitta, S. Fiorini, G. E. Cognigni, M. Filicori, and A. M. Morselli-Labate Effect of Long-Term Treatment with Metformin Added to Hypocaloric Diet on Body Composition, Fat Distribution, and Androgen and Insulin Levels in Abdominally Obese Women with and without the Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2767 - 2774. [Abstract] [Full Text]

				C. W. Martin, S. C. Riley, D. Everington, N. P. Groome, R. A. Riemersma, D. T. Baird, and R. A. Anderson Dose-finding study of oral desogestrel with testosterone pellets for suppression of the pituitary-testicular axis in normal men Hum. Reprod., July 1, 2000; 15(7): 1515 - 1524. [Abstract] [Full Text] [PDF]

				S. J. Winters, D. E. Kelley, and B. Goodpaster The analog free testosterone assay: are the results in men clinically useful? Clin. Chem., October 1, 1998; 44(10): 2178 - 2182. [Abstract] [Full Text] [PDF]

				M R Zacharin and G L Warne Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets Arch. Dis. Child., June 1, 1997; 76(6): 495 - 499. [Abstract] [Full Text]